Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study (Q34791688)
scientific article
Language:
(P31) (Q13442814)
(P304) 317-331
(P407) (Q1860)
(P433) 3
(P478) 200
(P577) Friday, July 4, 2008
(P921) (Q269829)
(Q6934595)
(Q41112)
(P1433) (Q1422802)
(P1476) "Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study" (language: en)
(P2093) Daniel E Casey
Earl E Sands
Jens Heisterberg
Hwa-Ming Yang
(P2860) (Q21999020)
(Q41072344)
(Q28301751)
(Q28305811)
(Q34453369)
(Q46792869)
(Q34554069)
(Q34668688)
(Q34744755)
(Q44446769)
(Q36178194)
(Q34534321)
(Q35080804)
(Q29614468)
(Q35688765)
(Q34455790)
(Q50938126)
(Q45206310)
(Q36590638)
(Q42544512)
(Q33964839)
(Q34293049)
(Q36457692)
(Q28273164)
(Q28251670)
(Q44513113)
(Q24685521)
(Q34393559)
(Q34583697)
(Q74405733)
(Q36835772)
(Q28236854)
(Q78318718)
(Q40301045)
(Q33988376)
(Q35832656)
(Q34247423)
(Q40545893)
(Q46550452)
(Q36248015)
(Q46683011)
(Q34551484)
(Q35793345)
(Q40824415)
(Q45052998)
(Q83832575)
(Q36336286)
other details
description scientific article

External Links